other material
confidence high
sentiment positive
materiality 0.35
Estrella Immunopharma authorizes up to $1M share repurchase
Estrella Immunopharma, Inc.
- Board authorized up to $1 million of common stock repurchases; no binding commitment.
- Timing, amount and method of repurchases to be determined by market conditions.
- CEO and CFO state authorization reflects confidence in Estrella's value and strategic direction.
- Repurchase program covers stock traded on Nasdaq under ticker ESLA.